Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in INMB — Inmune Bio, Inc.

CIK 1390777 NEW YORK, NY
Back to INMB Full portfolio

Position in INMB

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$34,602
-$25,996 QoQ
Shares Held
21,229
-60.4% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 83 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. INMB ranks #296 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in INMB

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,602 21,229
2026-03-31 $60,598 53,628
2025-12-31 $91,292 58,521
2025-09-30 $123,889 59,851
2025-06-30 $142,303 61,604
2025-03-31 $428,945 54,923
2024-12-31 $235,375 50,402
2024-09-30 $267,084 49,552
2024-06-30 $516,851 58,600
2024-03-31 $306,545 26,089
2023-12-31 $376,084 33,400
2023-09-30 $222,671 32,891